Low meprin α expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries
Authors:
- Viola A Heinzelmann-SchwarzVHViola A Heinzelmann-Schwarz
- Richard A ScolyerRichard A Scolyer
- James P ScurryJSJames P Scurry
- Alison N SmithASAlison N Smith
- Margaret Gardiner-GardenMGMargaret Gardiner-Garden
- Andrew V BiankinABAndrew V Biankin
- Sally Baron-HaySBSally Baron-Hay
- Carolyn ScottCSCarolyn Scott
- Robyn L WardRWRobyn L Ward
- Daniel FinkDFDaniel Fink
- Neville F HackerNHNeville F Hacker
- Robert L SutherlandRSRobert L Sutherland
- 5 July 2006
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (6) , 622-626
Abstract
Background: Currently, no specific immunohistochemical markers are available to differentiate primary mucinous epithelial ovarian cancer (MOC) from adenocarcinomas originating at other sites that have metastasised to the ovary, which may have an impact on patient management and prognosis. Aim: To investigate the expression of two intestinal markers, galectin 4 and meprin α, in mucinous carcinomas of the ovary and gastrointestinal tract. Methods: Using immunohistochemical analysis, the expression of galectin 4 and meprin α was investigated in 10 MOCs and in 38 mucinous adenocarcinomas of colon, pancreas, stomach and appendix, the most common sites of origin of ovarian metastases. Results: Total cytoplasmic galectin 4 expression was relatively consistent between the different carcinomas. Membranous meprin α expression was significantly lower in MOCs compared with gastrointestinal carcinomas. Moreover, meprin α expression showed greater discrimination between the ovarian and gastrointestinal carcinomas than the cytokeratins CK7 and CK20, the current standard immunohistochemical markers used to determine the tissue origin of mucinous carcinomas involving the ovaries. Conclusions: Meprin α is a useful additional marker in differentiating primary from secondary mucinous adenocarcinomas of the ovary.Keywords
This publication has 27 references indexed in Scilit:
- Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinomaLaboratory Investigation, 2005
- The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomasLaboratory Investigation, 2004
- CDX-2 immunostaining in primary and secondary ovarian carcinomasJournal of Clinical Pathology, 2004
- The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial OriginInternational Journal of Gynecological Pathology, 2004
- The Value of Cdx2 Immunostaining in Differentiating Primary Ovarian Carcinomas From Colonic Carcinomas Metastatic to the OvariesInternational Journal of Gynecological Pathology, 2004
- Galectin-4 in normal tissues and cancerGlycoconjugate Journal, 2003
- Evaluation of Diagnostic Criteria and Behavior of Ovarian Intestinal-Type Mucinous TumorsAmerican Journal of Surgical Pathology, 1999
- Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma.1999
- Cloning and Expression of the mRNA of Human Galectin‐4, an S‐type Lectin Down‐Regulated in Colorectal CancerEuropean Journal of Biochemistry, 1997
- A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.Journal of Clinical Pathology, 1995